首页> 中文期刊> 《临床与转化肝病杂志(英文版)》 >Mitochondrial Damage and Drp1 Overexpression in Rifampicin-and Isoniazid-induced Liver Injury Cell Model

Mitochondrial Damage and Drp1 Overexpression in Rifampicin-and Isoniazid-induced Liver Injury Cell Model

         

摘要

Background and Aims:Rifampicin (RFP) and isoniazid (INH) are widely used as anti-tuberculosis agents.However,the mechanisms underlying the involvement of reactive oxygen species and mitochondria in RFP-and INH-related hepatotoxicity have not been established yet.This study aimed to observe the intracellular mechanisms leading to mitochondrial dysfunction and morphological changes in RFP-and INH-induced hepatocyte injury.Methods:Cell injury,changes in mitochondrial function,and expression and activation of dynamin related protein 1 (Drp1),known as the main protein for mitochondrial fission,were analyzed in cultured QSG7701 cells exposed to RFP and INH.Results:INH and RFP treatment induced pronounced hepatocyte injury and increased cell death.In the similar context of aspartate aminotransferase elevation and adenosine triphosphate synthesis decrease,changes in mitochondrial membrane permeability and reactive oxygen species in hepatocytes induced by RFP were significantly different from those induced by INH (p < 0.05).Particularly,we observed the overactivation and mitochondrial translocation of Drp1 in RFP-induced cell injury,which was not occurred with exposure to INH.Conclusions:RFP-induced hepatotoxicity may be closely related to mitochondrial dysfunction and Drp1-mediated mitochondrial fission.

著录项

  • 来源
    《临床与转化肝病杂志(英文版)》 |2019年第1期|40-45|共6页
  • 作者单位

    Department of Digestive Diseases,First Hospital of Chenzhou, Chenzhou, Hunan, China;

    Department of Infectious Diseases, The Affiliated Zhuzhou Hospital Xiangya Medical College CSU, Zhuzhou, Hunan, China;

    Liver Diseases Center, Department of Infectious Diseases, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China;

    Department of Infectious Diseases, First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China;

    Department of Liver Diseases, Third Hospital of Shenzhen, Shenzhen, Guangdong, China;

  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号